| AstraZeneca AG - Brilique 90 mg, Schmelztabletten | | 66822 | | 01 | | Brilique 90 mg | | Schmelztabletten | | B01AC24 | | Ticagrelor | | 08.03.2018 | | |
| | Composition | | ticagrelorum 90 mg, mannitolum, cellulosum microcristallinum, crospovidonum, xylitolum, calcii hydrogenophosphas, natrii stearylis fumaras, hydroxypropylcellulosum, silica colloidalis anhydrica, pro compresso corresp. natrium 0.53 mg. | | Packungsbestandteile | | Melting tablets | | | | Active Agent | Dose |
|---|
| Ticagrelorum | 90 mg |
| | | | Inactive agents |
|---|
| Calcium Hydrogen Phosphate | | Cellulosum Microcristallinum | | Crospovidonum | | Hydroxypropylcellulosum | | Mannitol | | Natrii Stearylis Fumaras | | Pro Compresso | | Silica Colloidalis Anhydrica | | Xylitol |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 10 | | | B | | No |
|
|
